Suchergebnisse - "Poggio, F"

PubPharm (56)

1

Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer : the end of the debate

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Poggio, F. | Tagliamento, M. | Ceppi, M. | +7

CommentIn: Ann Oncol. 2022 Jun;33(6):658-659. - PMID 35306157

2

Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab : a multicenter, phase II, single arm trial (GIM11-BERGI)

enthalten in: ESMO open | 2021

von De Angelis, C. | Bruzzese, D. | Bernardo, A. | +16

ErratumIn: ESMO Open. 2021 Apr;6(2):100097. - PMID 33926709

3

Corrigendum to 'Eribulin in combination with bevacizumab as second-line treatment for HER2-negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab : a multicenter, phase II, single arm trial (GIM11-BERGI)': [ESMO Open Volume 6, Issue 2, April 2021, 100054

enthalten in: ESMO open | 2021

von De Angelis, C. | Bruzzese, D. | Bernardo, A. | +18

ErratumFor: ESMO Open. 2021 Feb 15;6(2):100054. - PMID 33601296

4

VISTA: A Promising Target for Cancer Immunotherapy?

in: ImmunoTargets and Therapy | 2021

von Tagliamento M | Agostinetto E | Borea R | +4

5

Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer : a systematic review and meta-analysis

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2018

von Poggio, F. | Bruzzone, M. | Ceppi, M. | +5

6

Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients : a systematic review and meta-analysis

enthalten in: Breast (Edinburgh, Scotland) | 2017

von Poggio, F. | Ceppi, M. | Lambertini, M. | +11

7

The prognostic performance of Adjuvant! Online and Nottingham Prognostic Index in young breast cancer patients: an international multicentre hospital-based retrospective cohort study

enthalten in: Annals of oncology | 2016

von Lambertini, M. | Pinto, A. | Ameye, L. | +12

8

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients : a meta-analysis of randomized studies

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Lambertini, M. | Ceppi, M. | Poggio, F. | +9

CommentIn: Ann Oncol. 2016 Mar;27(3):548-9. - PMID 26646756

9

Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies

enthalten in: Annals of oncology | 2015

von Lambertini, M. | Ceppi, M. | Poggio, F. | +9

10

OR30 Prospective study of fertility preservation strategies in young early breast cancer patients: the PREFER (pregnancy and fertility) trial

enthalten in: The breast | 2014

von Lambertini, M. | Anserini, P. | Poggio, F. | +7

1
2
3
4
5
6
Nächster »
[6]